AUPM399594A0 - Antigenic preparation for treatment or prevention of helicobacter infection - Google Patents

Antigenic preparation for treatment or prevention of helicobacter infection

Info

Publication number
AUPM399594A0
AUPM399594A0 AUPM3995A AUPM399594A AUPM399594A0 AU PM399594 A0 AUPM399594 A0 AU PM399594A0 AU PM3995 A AUPM3995 A AU PM3995A AU PM399594 A AUPM399594 A AU PM399594A AU PM399594 A0 AUPM399594 A0 AU PM399594A0
Authority
AU
Australia
Prior art keywords
prevention
treatment
antigenic preparation
helicobacter infection
helicobacter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPM3995A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CSL Ltd
UNSW Sydney
Original Assignee
CSL Ltd
UNSW Sydney
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CSL Ltd, UNSW Sydney filed Critical CSL Ltd
Priority to AUPM3995A priority Critical patent/AUPM399594A0/en
Publication of AUPM399594A0 publication Critical patent/AUPM399594A0/en
Priority to HK98103784.7A priority patent/HK1004677B/en
Priority to KR1019960704542A priority patent/KR100351534B1/ko
Priority to CA002182274A priority patent/CA2182274C/en
Priority to AU18011/95A priority patent/AU693864B2/en
Priority to NZ329879A priority patent/NZ329879A/en
Priority to JP7521469A priority patent/JPH10500102A/ja
Priority to US08/687,434 priority patent/US6663873B2/en
Priority to EP95909582A priority patent/EP0804489B1/en
Priority to DE69527986T priority patent/DE69527986T2/de
Priority to PCT/AU1995/000077 priority patent/WO1995022563A1/en
Priority to NZ281146A priority patent/NZ281146A/en
Priority to AT95909582T priority patent/ATE222930T1/de
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/121—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Helicobacter (Campylobacter) (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AUPM3995A 1994-02-21 1994-02-21 Antigenic preparation for treatment or prevention of helicobacter infection Abandoned AUPM399594A0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
AUPM3995A AUPM399594A0 (en) 1994-02-21 1994-02-21 Antigenic preparation for treatment or prevention of helicobacter infection
AT95909582T ATE222930T1 (de) 1994-02-21 1995-02-17 Antigene arznei zur behandlung oder vorbeugung
JP7521469A JPH10500102A (ja) 1994-02-21 1995-02-17 Ｈｅｌｉｃｏｂａｃｔｅｒ感染の治療または予防用の抗原製剤
KR1019960704542A KR100351534B1 (ko) 1994-02-21 1995-02-17 헬리코박터감염의치료또는예방용항원제제
CA002182274A CA2182274C (en) 1994-02-21 1995-02-17 Antigenic preparation for treatment or prevention of helicobacter infection
AU18011/95A AU693864B2 (en) 1994-02-21 1995-02-17 Antigenic preparation for treatment or prevention of helicobacter infection
NZ329879A NZ329879A (en) 1994-02-21 1995-02-17 Treating helicobacter infection with antigenic vaccine of lipopolysaccharide (lps) of helicobacter bacteria or fragment thereof
HK98103784.7A HK1004677B (en) 1994-02-21 1995-02-17 Antigenic preparation for treatment or prevention of helicobacter infection
US08/687,434 US6663873B2 (en) 1994-02-21 1995-02-17 Antigenic preparation for treatment or prevention of helicobacter infection
EP95909582A EP0804489B1 (en) 1994-02-21 1995-02-17 Antigenic preparation for treatment or prevention of helicobacter infection
DE69527986T DE69527986T2 (de) 1994-02-21 1995-02-17 Antigene arznei zur behandlung oder vorbeugung
PCT/AU1995/000077 WO1995022563A1 (en) 1994-02-21 1995-02-17 Antigenic preparation for treatment or prevention of helicobacter infection
NZ281146A NZ281146A (en) 1994-02-21 1995-02-17 Antigenic preparation of helicobacter bacteria lipopolysaccharide and its use in treating helicobacter infection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPM3995A AUPM399594A0 (en) 1994-02-21 1994-02-21 Antigenic preparation for treatment or prevention of helicobacter infection

Publications (1)

Publication Number Publication Date
AUPM399594A0 true AUPM399594A0 (en) 1994-03-17

Family

ID=3778612

Family Applications (2)

Application Number Title Priority Date Filing Date
AUPM3995A Abandoned AUPM399594A0 (en) 1994-02-21 1994-02-21 Antigenic preparation for treatment or prevention of helicobacter infection
AU18011/95A Ceased AU693864B2 (en) 1994-02-21 1995-02-17 Antigenic preparation for treatment or prevention of helicobacter infection

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU18011/95A Ceased AU693864B2 (en) 1994-02-21 1995-02-17 Antigenic preparation for treatment or prevention of helicobacter infection

Country Status (10)

Country Link
US (1) US6663873B2 (cg-RX-API-DMAC10.html)
EP (1) EP0804489B1 (cg-RX-API-DMAC10.html)
JP (1) JPH10500102A (cg-RX-API-DMAC10.html)
KR (1) KR100351534B1 (cg-RX-API-DMAC10.html)
AT (1) ATE222930T1 (cg-RX-API-DMAC10.html)
AU (2) AUPM399594A0 (cg-RX-API-DMAC10.html)
CA (1) CA2182274C (cg-RX-API-DMAC10.html)
DE (1) DE69527986T2 (cg-RX-API-DMAC10.html)
NZ (2) NZ281146A (cg-RX-API-DMAC10.html)
WO (1) WO1995022563A1 (cg-RX-API-DMAC10.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPM399594A0 (en) * 1994-02-21 1994-03-17 Csl Limited Antigenic preparation for treatment or prevention of helicobacter infection
US5681736A (en) * 1994-10-05 1997-10-28 Antex Biologics, Inc. Methods for producing enhanced antigenic shigella bacteria and vaccines comprising same
DK0792347T3 (da) * 1994-10-05 2006-04-03 Emergent Immunosolutions Inc Fremgangsmåder til fremstilling af forbedrede antigene Heliobacter sp. og vacciner omfattende samme
AU693679B2 (en) * 1995-04-21 1998-07-02 Csl Limited Protective helicobacter antigens
CA2217496A1 (en) 1995-04-21 1996-10-24 Csl Limited Protective helicobacter antigens
AU6583398A (en) * 1997-03-26 1998-10-20 Avant Immunotherapeutics, Inc. Polypeptides which immunoreact with polyclonal antisera against (h. pylori)
GB9715702D0 (en) * 1997-07-24 1997-10-01 Univ Bristol Bacterial isolate
US6599509B2 (en) 1997-09-02 2003-07-29 Massachusetts Institute Of Technology Compositions and methods comprising helicobacter antigens for treatment and prevention of inflammatory bowel disease
JP4054681B2 (ja) * 2001-02-21 2008-02-27 デンカ生研株式会社 ヘリコバクター・ピロリを認識する抗体、およびヘリコバクター・ピロリを検出する方法
DE102004024674A1 (de) * 2004-05-18 2005-12-15 Wolfgang Lorenz Mittel und Verfahren zur Diagnose, Prophylaxe und Therapie von Bindegewebserkrankungen
WO2007018152A1 (ja) 2005-08-05 2007-02-15 The University Of Tokushima IgA抗体の選択的産生からIgA及びIgG両抗体産生への切換えを可能にする抗原薬物ビークルとこれを用いる経鼻・粘膜ワクチン
PT2945651T (pt) 2013-01-17 2018-06-12 Arsanis Biosciences Gmbh Anticorpo específico para mdr e. coli
CN113388032A (zh) 2014-02-06 2021-09-14 X4制药(奥地利)有限责任公司 大肠杆菌特异性抗体序列
PL3110441T3 (pl) 2014-02-24 2024-08-05 Glaxosmithkline Biologicals S.A. Nowatorski polisacharyd i jego zastosowania
TWI715617B (zh) 2015-08-24 2021-01-11 比利時商葛蘭素史密斯克藍生物品公司 對抗腸道外病原性大腸桿菌之免疫保護之方法及組合物
AR109621A1 (es) 2016-10-24 2018-12-26 Janssen Pharmaceuticals Inc Formulaciones de vacunas contra glucoconjugados de expec
IL286467B1 (en) 2019-03-18 2025-10-01 Janssen Pharmaceuticals Inc Methods for producing bioconjugates of E. COLI O-antigen polysaccharides, preparations thereof and methods for using them
IL286394B2 (en) 2019-03-18 2025-10-01 Janssen Pharmaceuticals Inc E. COLI O-antigen polysaccharide bioconjugates, methods for their production and methods for their use
CN111467368B (zh) * 2020-04-13 2021-05-28 江南大学 含庚糖链的寡糖化合物在制备幽门螺旋杆菌疫苗中的应用
JP7481585B2 (ja) 2020-09-17 2024-05-10 ヤンセン ファーマシューティカルズ，インコーポレーテッド 多価ワクチン組成物及びその使用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU644121B2 (en) * 1989-12-04 1993-12-02 Auspharm International Limited Rapid in vitro test for helicobacter pylori using saliva
US5217872A (en) * 1990-02-27 1993-06-08 The United States Of America As Represented By The Department Of Health And Human Services Method for detection of borrelia burgdorferi antigens
US5098755A (en) * 1990-11-21 1992-03-24 Tanquary Albert C Textured thermoplastic elastomeric film, articles comprising same, and method of making such textured thermoplastic elastomeric film and articles
MX9301706A (es) 1992-04-13 1994-05-31 Oravax Inc Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
US5580563A (en) * 1992-05-01 1996-12-03 Tam; James P. Multiple antigen peptide system having adjuvant properties, vaccines prepared therefrom and methods of use thereof
US5843460A (en) * 1993-05-19 1998-12-01 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides
US5871749A (en) * 1993-07-27 1999-02-16 Csl Limited Therapeutic treatment of H. pylori associated gastroduodenal disease
US6406703B1 (en) * 1993-07-27 2002-06-18 Csl Limited Treatment of H. pylori associated gastroduodenal disease
US5840302A (en) * 1993-11-10 1998-11-24 Bristol-Myers Squibb Company Treatment of bacterially-induced inflammatory diseases
AUPM399594A0 (en) * 1994-02-21 1994-03-17 Csl Limited Antigenic preparation for treatment or prevention of helicobacter infection
AUPM612494A0 (en) * 1994-06-08 1994-06-30 Csl Limited Treatment or prevention of helicobacter infection
US5681736A (en) * 1994-10-05 1997-10-28 Antex Biologics, Inc. Methods for producing enhanced antigenic shigella bacteria and vaccines comprising same
CA2217496A1 (en) * 1995-04-21 1996-10-24 Csl Limited Protective helicobacter antigens
US5997881A (en) * 1995-11-22 1999-12-07 University Of Maryland, Baltimore Method of making non-pyrogenic lipopolysaccharide or A
AU3458299A (en) * 1998-03-31 1999-10-18 United States Of America, As Represented By The Secretary Of Agriculture, The Monoclonal antibodies against (campylobacter jejuni) and (campylobacter coli) outer membrane antigens
KR20010088302A (ko) * 1998-06-19 2001-09-26 추후 제출 헬리코박터 감염에 대한 비경구 면역화 방법에 있어서의ｌｔ 및 ｃｔ

Also Published As

Publication number Publication date
CA2182274C (en) 2007-05-22
ATE222930T1 (de) 2002-09-15
CA2182274A1 (en) 1995-08-24
NZ329879A (en) 1999-10-28
EP0804489B1 (en) 2002-08-28
WO1995022563A1 (en) 1995-08-24
US20020122794A1 (en) 2002-09-05
JPH10500102A (ja) 1998-01-06
AU1801195A (en) 1995-09-04
KR970701209A (ko) 1997-03-17
DE69527986T2 (de) 2003-04-10
KR100351534B1 (ko) 2003-03-15
US6663873B2 (en) 2003-12-16
NZ281146A (en) 1998-04-27
EP0804489A4 (cg-RX-API-DMAC10.html) 1997-11-19
AU693864B2 (en) 1998-07-09
HK1004677A1 (en) 1998-12-04
EP0804489A1 (en) 1997-11-05
DE69527986D1 (de) 2002-10-02

Similar Documents

Publication Publication Date Title
AUPM399594A0 (en) Antigenic preparation for treatment or prevention of helicobacter infection
AUPM612494A0 (en) Treatment or prevention of helicobacter infection
AU1199900A (en) Use of purified invaplex from gram negative bacteria as a vaccine
GB2303854B (en) Helicobacter proteins and vaccines
PT2277536T (pt) Purificação de polissacáridos capsulares bacterianos
AU6875398A (en) Methods of producing and using virulence attenuated (poxr) mutant bacteria
NZ314585A (en) Method of treating H. Pylori associated gastroduodenal disease
AU3580800A (en) Method of and compositions for immunization with the (pseudomonas) v antigen
AU2238597A (en) Iscom or iscom-matrix comprising a mucus targetting substance and optionally, an antigen
AU3853495A (en) Immunogenic compositions
NZ335050A (en) Helicobacter pylori live vaccine
WO2000050073A3 (en) Caulobacter lps immunoadjuvant
AU6580494A (en) Use of clioquinol for treating helicobacter, including (h. pylori), infections and related diseases
NZ332809A (en) Immunogenic complex comprising a oligo- or polysaccharide epitope and a carrier protein with a portion of an OmpA-type outer membrane protein of a bacterial and vaccines of such complexes containing same
AU2790095A (en) Thiopyridines for combating (helicobacter) bacteria
AU4672896A (en) Helicobacter pylori antigen
AU5091898A (en) Method of vaccinating infants against infections
CA2191440A1 (en) Treatment and prevention of helicobacter infection
GB9018061D0 (en) Compositions for vaccines
NZ331674A (en) Use of antigenic preparations comprising Helicobacter catalase for treating or preventing Helicobacter infection
AU8464398A (en) Urease based vaccine against (helicobacter) infection
MX9700215A (es) Proteinas y vacunas de helicobacter.
HK1036807A (en) Peptide fragments os cholera toxin b or enterotoxin b as vaccine adjuvants
MX9708226A (es) Vacunas que contienen una saponina y un esterol.
AUPN745196A0 (en) Vaccine for porcine enzootic pneumonia